PRELIMINARY PROGRAM OF THE 7th EUROPEAN ELASTIN MEETING 2012 Saturday September 1st 2012 16:00-18:30 registration 18:30
opening lecture: L. Sakai: [Title to be announced]
Sunday September 2nd 2012 8:00-9:00: registration Session I: Microfibrils and elastic fibres: structure, assembly and function Chair: B. Bochicchio - Z. Urban 09:00-09:20 A. Weiss: Coupled functional modules in tropoelastin: a 3D perspective 09:25-09:45 V. Samouillan: Low frequency chain dynamics of synthetic fragments inspired
from human tropoelastin: signature of the amyloid structure
09:50-10:10 A. Alix: The new concept of Morpho-matrikines applied to Morpho-elastokines
10:15-10:35 D. Reinhardt: Role of fibronectin in the regulation of elastic fibres in vivo 10:45-11:15: coffee break 11:15-11:35 MP. Jacob: Regulation of elastin synthesis in the aorta
11:40-12:00 C. Baldock: [Title to be announced] 12:05-12:25 E. Davis: [Title to be announced] 12:30-12:55 S. Rauscher: Elastin-like aggregation, elastomeric properties and the liquid
13:00-15:00: lunch 15:00-16:45: poster session 16:45-17:15: coffee break Session II: Elastogenic engineering and biomaterials Chair: A. Weiss 17:15-17:35 B. Bochicchio: Elastomeric protein-inspired biomaterials
17:40-18:00 FJ. Arias: Elastin-like recombinamers 18:05-18:25 J. Attia : Rejuvenation of human dermis by an elastokine-derived
18:30-18:50 L. Muiznieks: Proline-poor biomaterials: the effect of human and rat domain 30
on elastin assembly and mechanical properties
PRELIMINARY PROGRAM OF THE 7th EUROPEAN ELASTIN MEETING 2012
Monday September 3rd 2012 Session III: Animal models Chair: E. Davis 09:00-09:20 B. Kozel: Of mice and men: modifiers of elastin insufficiency
09:25-09:45 J. Essers: Animal studies in aneurysmal disease
09:50-10:10 A. Willaert: Zebrafish models for elastinopathies
10:15-10:35 C. Craft: Characterization of the MAGP1 knock-out mouse model 10:45-11:15: coffee break Session IV: Elastic fibre-associated cell signalling and epigenetics Chair: P. Sommer 11:15-11:35 Z. Urban: Cell signalling in cutis laxa
11:40-12:00 O. Vanakker: BMP-signalling in pseudoxanthoma elasticum 12:05-12:25 D. Quaglino: Mechanisms and regulation of elastic fibre calcification
12:30-12:55 L. Duca: Elastine receptor complex in cell survival and differentiation
13:00-13:20 P. Sommer: Epigenetics and elastic fibre regulation 13:25-14:30: lunch Free afternoon 20:00 PRELIMINARY PROGRAM OF THE 7th EUROPEAN ELASTIN MEETING 2012
Tuesday September 4th 2012 Session V: Heritable and acquired elastic fibre diseases Chair: D. Quaglino - F. Keeley 09:00-09:20 J. De Backer: Elastin mutations in the Williams-Beuren syndrome 09:25-09:45 G. Lefthériotis: The vascular phenotype in pseudoxanthoma elasticum and
09:50-10:10 L. Robert: A novel elastinopathy 10:15-10:35 J. Bujan: [Title to be announced] 10:45-11:15: coffee break 11:15-11:35 B. Callewaert: Hereditary cutis laxa syndromes: need for a reclassification? 11:40-12:00 J. Wagenseil: Elastin, arterial stiffness and hypertension
12:05-12:25 F. Ramirez: Genetic dissection of the cardiovascular pathogenesis in Marfan
12:30-12:55 S. Terry: [Title to be announced] 13:00-15:00: lunch 15:00-16:45: Selected talk session (Chair: B. Mecham) 16:45-17:15: coffee break Session VI: Therapeutic advances in elastinopathies Chair: J. Bujan 17:15-17:35 LA Perez-Jurado: Reduction of NADPH-oxidase (NOX) in Williams-Beuren
17:40-18:00 G. Faury: Stimulation of elastin production in aged mice by minoxidil 18:05-18:25 [To be announced] 18:30-18:50 [To be announced] 18:55: end of day / Closing remarks
Periodontics Written Report – Example I. MEDICAL HISTORY: The patient is a 47-year-old Caucasian male, 6' 1" tall, weighing 190 lbs. He is married, and works as a safety systems technician. He smokes one pack of cigarettes per day and consumes 7 to 8 beers per week. His baseline blood pressure was 114/74 with a regular pulse of 65 beats per minute and respirations at 15 per minute.
Doxycycline or Oral Corticosteroids for Nasal PolypsTherapeutic Options Beyond our Pages highlights randomized controlled trials published in other journals of novel therapeuticoptions for the conditions treated by allergist-immunologists. Generally written by Editorial Board members with relevantexpertise, this feature summarizes the methods and results of the study and then provides the author�